Study questions impact of GP pay incentives on patient care

May 27, 2009

The care of patients with diabetes has improved over the last decade, but this does not seem to be a direct result of the quality and outcomes framework - the scheme that rewards UK general practices for delivering quality care.

The scheme in its present form may even lead to reduced levels of care for some patients, say researchers in a paper published on bmj.com today.

The quality and outcomes framework was introduced in 2004 to improve standards of primary care by linking to performance indicators for all general practitioners in the UK. The management of diabetes includes targets for controlling blood pressure, and blood glucose levels. Payments are staged and are subject to minimum and maximum thresholds.

Since its introduction, a series of studies have suggested an improvement in the management of people with diabetes in primary care, but it is unclear whether this is a direct result of the scheme or reflects existing trends in response to other quality improvement strategies.

So researchers based at the Universities of Birmingham and Manchester assessed the proportion of patients meeting diabetes targets annually between 2001 and 2007 (three years prior to and following the introduction of the scheme). Their analysis included 147 general practices covering over one million patients across the UK.

They found significant improvements in all of the diabetes targets over the six year period, with consecutive annual improvements observed before the introduction of incentives.

However, these improvements in care appear to plateau after the introduction of the framework.

This could reflect the increasing difficulty of target attainment in poorly controlled patients, say the authors. However, it may also reflect the lack of further incentive after attainment of the upper payment thresholds (the ceiling effect).

If so, they suggest that upper thresholds may need to be removed or targets made more challenging if people are to benefit.

Another important finding was that up to two thirds of people with type 1 diabetes and a third of people with type 2 diabetes were not captured in the framework assessment. This needs to be addressed to reduce health inequalities, say the authors.

Our work and that of others highlights the potential unintended consequences of the scheme and raises concerns that the quality and outcomes framework may not have been as efficient in reducing inequalities in health in diabetes as was hoped, write the authors.

Although the management of with has improved since the late 1990s, the impact of the pay-for-performance initiative on care is not straightforward, they conclude.

Source: British Medical Journal (news : web)

Related Stories

Recommended for you

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.